We are international
Donate
•health professionals   TEXT SIZE   
webcasts    back

Dr. Knop - ASH 2008 - Anti-EGFR Antibody Cetuximab in Refractory or Relapsed Multiple Myeloma: Preliminary Results and Evaluation of Response Prediction in a Phase II Clinical Trial
Stephan Knop, MD
University Hospital Würzburg
Würzburg, Germany
12.27.08


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles